NZ576605A - Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases - Google Patents
Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseasesInfo
- Publication number
- NZ576605A NZ576605A NZ576605A NZ57660507A NZ576605A NZ 576605 A NZ576605 A NZ 576605A NZ 576605 A NZ576605 A NZ 576605A NZ 57660507 A NZ57660507 A NZ 57660507A NZ 576605 A NZ576605 A NZ 576605A
- Authority
- NZ
- New Zealand
- Prior art keywords
- notch3
- treatment
- related diseases
- agonist antibodies
- antibodies
- Prior art date
Links
Abstract
Disclosed are antibodies that bind to Notch3 by binding to an epitope in SEQ ID NO: 10 and activating Notch 3-mediated signalling. The antibodies can be used for treating a neurodegenerative disease, in particular CADSIL, familial hemiplegic migraine (FHM), familial paroxytic ataxia or Alagille syndrome.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85286106P | 2006-10-19 | 2006-10-19 | |
US87559706P | 2006-12-18 | 2006-12-18 | |
US87921807P | 2007-01-06 | 2007-01-06 | |
PCT/US2007/081797 WO2008051797A2 (en) | 2006-10-19 | 2007-10-18 | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ576605A true NZ576605A (en) | 2012-12-21 |
Family
ID=44671873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ576605A NZ576605A (en) | 2006-10-19 | 2007-10-18 | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
Country Status (3)
Country | Link |
---|---|
ES (1) | ES2585206T3 (en) |
IL (1) | IL198079A (en) |
NZ (1) | NZ576605A (en) |
-
2007
- 2007-10-18 NZ NZ576605A patent/NZ576605A/en not_active IP Right Cessation
- 2007-10-18 ES ES07844405.6T patent/ES2585206T3/en active Active
-
2009
- 2009-04-07 IL IL198079A patent/IL198079A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL198079A0 (en) | 2011-08-01 |
IL198079A (en) | 2014-05-28 |
ES2585206T3 (en) | 2016-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500576A1 (en) | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases | |
MX2009004986A (en) | Methods of treating hemolytic anemia. | |
UA95304C2 (en) | Use of dll4 antagonists for the prevention of vascular disorders | |
MY149630A (en) | Antibodies against amyloid-beta peptide | |
MX2009012950A (en) | Humanized antibodies to aã(20-42) globulomer and uses thereof. | |
WO2006138729A3 (en) | Receptor antagonists for treatment of metastatic bone cancer | |
AU2018256498A1 (en) | Antibodies to amyloid beta | |
NZ590131A (en) | Notch-binding agents and antagonists and methods of use thereof | |
UA116871C2 (en) | METHOD OF TREATMENT OF MYELODYLASPLASTIC SYNDROME, THALASEMIA AND SERIOUS-CELL ANEMIA WITH THE USE OF ACTIVIPURIA ANTAGONISTU ANTAGONIST | |
UA109658C2 (en) | ANTIBODY AGAINST CGRP | |
MXPA06014510A (en) | Compositions and methods for treating inflammatory disorders. | |
MY151191A (en) | Novel antibodies | |
PE20091193A1 (en) | HUMAN ANTIGEN BINDING PROTEINS FROM GM-CSF | |
IL183165A (en) | Polypeptides derived from the extracellular portion of the trem-1 protein and capable of acting as antagonist of the trem-1 protein, compositions comprising the same and use thereof in the manufacture of medicaments for treatment of sepsis, septic shock and sepsis-like conditions | |
NZ598063A (en) | Gram-positive bacteria specific binding compounds | |
MX2010002716A (en) | Neuroendocrine factors for treatment of degenerative diseases. | |
BRPI0908276B8 (en) | use of an anti-cgrp antagonist antibody for the manufacture of a drug for the prevention and/or treatment of osteoarthritis pain | |
HK1096392A1 (en) | Substituted heterocycles | |
WO2008091641A3 (en) | Compositions and methods for diagnosing and treating cancer | |
WO2009142738A3 (en) | Compositions and methods for diagnosing and treating cancer | |
DE602006019977D1 (en) | THERAPY WITH ANTI-CD4 ANTIBODIES AND IRRADIATION | |
AR093182A1 (en) | METHOD TO TREAT OVERWEIGHT OR OBESITY | |
UA94213C2 (en) | Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease | |
BRPI0409562A (en) | treatment of conditions involving amyloid plaques | |
NO20081453L (en) | Compositions and methods for the diagnosis and treatment of inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: GENENTECH, INC., US Free format text: OLD OWNER(S): TANOX, INC. |
|
S883 | Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant) |
Free format text: THE PRIORITY DETAILS (31), (32) AND (33) HAVE BEEN CORRECTED |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 18 OCT 2014 BY AJ PARK Effective date: 20130509 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 18 OCT 2017 BY THOMSON REUTERS Effective date: 20140912 |
|
LAPS | Patent lapsed |